In a report issued on January 15, Steven Valiquette from Barclays maintained a Purchase score on UnitedHealth (UNH – Analysis Report), with a price goal of $405.00. The corporate’s shares closed final Friday at $351.30, near its 52-week excessive of $367.95.
In line with TipRanks.com, Valiquette is a 3-star analyst with a median return of 3.1% and a 56.8% success price. Valiquette covers the Healthcare sector, specializing in stocks reminiscent of Patterson Corporations, AmerisourceBergen, and Neighborhood Well being.
UnitedHealth has an analyst consensus of Sturdy Purchase, with a price goal consensus of $397.12, implying a 13.7% upside from present ranges. In a report issued on January 5, Truist Monetary additionally maintained a Purchase score on the stock with a $420.00 price goal.
See immediately’s analyst high advisable stocks >>
UnitedHealth’s market cap is at present $333.3B and has a P/E ratio of 20.20. The corporate has a price to Ebook ratio of -25.19.
Based mostly on the latest company insider exercise of 138 insiders, company insider sentiment is unfavourable on the stock. Which means that over the previous quarter there was a rise of insiders promoting their shares of UNH in relation to earlier this 12 months.
TipRanks has tracked 36,00zero firm insiders and located that a number of of them are higher than others relating to timing their transactions. See which 3 stocks are most probably to make strikes following their insider actions.
UnitedHealth Group, Inc. engages within the provision of well being care protection, software program, and knowledge consultancy providers. It operates by way of the next segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare phase makes use of Optum’s capabilities to assist coordinate affected person care, enhance affordability of medical care, analyze price developments, handle pharmacy advantages, work with care suppliers extra successfully, and create an easier client expertise. The OptumHealth phase offers well being providers enterprise serving the broad well being care market, together with payers, care suppliers, employers, authorities, life sciences corporations, and shoppers. The OptumInsight phase focuses on knowledge and analytics, expertise, and knowledge to assist main members within the well being care business. The OptumRx phase offers pharmacy care providers. The corporate was based by Richard T. Burke in January 1977 and is headquartered in Minneapolis, MN.